Clinical Effect of Implantable Cardioverter Defibrillator Replacements : – When Should You Resume Driving After an Implantable Cardioverter Defibrillator Replacement? –
スポンサーリンク
概要
- 論文の詳細を見る
Background: The intervals of the driving restrictions after an implantable cardioverter defibrillator (ICD) replacement vary across the different countries around the world. However, little is known regarding the appropriate duration for driving restrictions after an ICD replacement. The aim of this study was to investigate the clinical effect of ICD replacements and to elucidate when to resume driving an automobile after an ICD replacement. Methods and Results: The study reviewed 139 consecutive patients with an ICD replacement in order to evaluate the incidence of ICD therapies before and after ICD replacements, and to assess the time-dependence of the ICD therapies after the ICD replacement. There was no significant difference in the incidence of ICD therapies delivered during durations of 3 months and 6 months before and after the ICD replacement (P=0.28, and 1.0, respectively). ICD therapies after the replacements were observed in 8.6% of the patients who were legally eligible to drive according to the Japanese guidelines at 1 year, and that was associated with a relatively low annual risk of death or injury to others. Conclusions: Implantable cardioverter defibrillator replacements did not affect the future ICD therapies under similar algorithms. The appropriate interval for driving restrictions after an ICD replacement is recommended to be a week or so, with a system integrity check performed before resumption of driving. (Circ J 2010; 74: 2301-2307)
論文 | ランダム
- G-207 21世紀の理科学習のすがた : CSからCDへ
- 液晶ディスプレイ用リソグラフィー技術の現状(IT革命に向けたリソグラフィー技術論文)
- EUにおける航空会社-空港の垂直的統合と競争政策上の課題
- 航空会社における事業の国際化と経営業績との関係についての分析
- 欧州格安航空会社のご利用はスマートに